Live birth and maternity outcome in childhood and adolescent cancer survivors under 18 years at diagnosis: a 40-year population-based cohort study

IF 6.4 1区 医学 Q1 ONCOLOGY
W. H. Wallace, T. W. Kelsey, D. Morrison, R. A. Anderson
{"title":"Live birth and maternity outcome in childhood and adolescent cancer survivors under 18 years at diagnosis: a 40-year population-based cohort study","authors":"W. H. Wallace, T. W. Kelsey, D. Morrison, R. A. Anderson","doi":"10.1038/s41416-024-02818-0","DOIUrl":null,"url":null,"abstract":"Survival from childhood and adolescent cancer has increased, but the chance of a livebirth in female survivors under 18 years at diagnosis may be reduced. We performed a national population-based analysis, including all female cancer survivors diagnosed in Scotland before the age of 18 years between 1981 and 2012. Scottish Cancer Registry records were linked to Scottish maternity records. Females from the exposed group with no pregnancies before cancer diagnosis (n = 2118) were compared with three general population controls matched for age and year of diagnosis. The cumulative incidence of a livebirth for all diagnoses was reduced to 37% (95% CI 33–40%) for cancer survivors at 30 years of age vs 58% (57–60%) for controls. The deficit varying by diagnosis: for lymphoid leukaemia, the cumulative incidence at 30 years was 29% (23–36%) vs 57% (52–61%) for controls with similar deficits in CNS tumours and retinoblastoma. There was a steady improvement in the chance of livebirth in those diagnosed more recently. We have shown a reduced chance of livebirth in female survivors of cancer diagnosed before age 18. The deficit is present for all diagnoses.","PeriodicalId":9243,"journal":{"name":"British Journal of Cancer","volume":null,"pages":null},"PeriodicalIF":6.4000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s41416-024-02818-0.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/s41416-024-02818-0","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Survival from childhood and adolescent cancer has increased, but the chance of a livebirth in female survivors under 18 years at diagnosis may be reduced. We performed a national population-based analysis, including all female cancer survivors diagnosed in Scotland before the age of 18 years between 1981 and 2012. Scottish Cancer Registry records were linked to Scottish maternity records. Females from the exposed group with no pregnancies before cancer diagnosis (n = 2118) were compared with three general population controls matched for age and year of diagnosis. The cumulative incidence of a livebirth for all diagnoses was reduced to 37% (95% CI 33–40%) for cancer survivors at 30 years of age vs 58% (57–60%) for controls. The deficit varying by diagnosis: for lymphoid leukaemia, the cumulative incidence at 30 years was 29% (23–36%) vs 57% (52–61%) for controls with similar deficits in CNS tumours and retinoblastoma. There was a steady improvement in the chance of livebirth in those diagnosed more recently. We have shown a reduced chance of livebirth in female survivors of cancer diagnosed before age 18. The deficit is present for all diagnoses.

Abstract Image

Abstract Image

确诊时未满 18 岁的儿童和青少年癌症幸存者的活产和分娩结果:一项为期 40 年的人群队列研究
背景儿童和青少年癌症的存活率有所提高,但确诊时未满 18 岁的女性幸存者的活产几率可能会降低。方法我们进行了一项基于全国人口的分析,其中包括 1981 年至 2012 年间苏格兰所有确诊时未满 18 岁的女性癌症幸存者。苏格兰癌症登记记录与苏格兰产科记录相链接。将癌症确诊前未怀孕的暴露组女性(n = 2118)与年龄和确诊年份相匹配的三个普通人群对照组进行了比较。研究结果癌症幸存者在 30 岁时所有确诊的活产累积发生率降至 37%(95% CI 33-40%),而对照组则为 58%(57-60%)。不同诊断导致的缺陷也不同:对于淋巴性白血病,30 岁时的累积发病率为 29%(23-36%),而对照组为 57%(52-61%),中枢神经系统肿瘤和视网膜母细胞瘤的缺陷也类似。最近确诊的癌症患者的活产几率稳步提高。所有诊断结果均显示出这种缺陷。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
British Journal of Cancer
British Journal of Cancer 医学-肿瘤学
CiteScore
15.10
自引率
1.10%
发文量
383
审稿时长
6 months
期刊介绍: The British Journal of Cancer is one of the most-cited general cancer journals, publishing significant advances in translational and clinical cancer research.It also publishes high-quality reviews and thought-provoking comment on all aspects of cancer prevention,diagnosis and treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信